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Abstract Paget’s disease (PD) is a chronic metabolically
active bone disease, characterized by a disturbance in bone
modelling and remodelling due to an increase in osteoblas-
tic and osteoclastic activity. The vertebra is the second most
commonly affected site. This article reviews the various
spinal pathomechanisms and osseous dynamics involved in
producing the varied imaging appearances and their clinical
relevance. Advanced imaging of osseous, articular and
bone marrow manifestations of PD in all the vertebral
components are presented. Pagetic changes often result in
clinical symptoms including back pain, spinal stenosis and
neural dysfunction. Various pathological complications due
to PD involvement result in these clinical symptoms.
Recognition of the imaging manifestations of spinal PD
and the potential complications that cause the clinical
symptoms enables accurate assessment of patients prior to
appropriate management.
Keywords Paget’sdisease.Vertebra.Spinalstenosis.
Magneticresonanceimaging.Computedtomography
Introduction
Paget’s disease (PD) or osteitis deformans is one of the
commonest metabolically active bone diseases, second in
prevalence only to osteoporosis, characterised by a distur-
bance in bone modelling and remodelling because of an
increase in osteoblastic and osteoclastic activity. It is more
common in people of Anglo Saxon origin and is less
common in the Far East, India, Middle East and Africa. The
overall prevalence of PD is 3–3.7% and increases with age
[1–3]. By the age of 90 years, the prevalence increases to
about 10% [2]. As the aetiology of PD continues to be the
subject of debate, it is variously classified as an infection,
metabolic disorder and a neoplastic process [1, 4–15].
However, strictly speaking, as the unaffected skeleton is
metabolically normal, it does not fulfil the criteria for a true
metabolic bone disorder.
The epidemiology of PD shows some significant
changing trends in the clinical profilometry. First, recent
studies have demonstrated that the incidence and preva-
lence of PD is gradually declining [16–18]. Second, there is
a general trend towards reduction in the severity of the
disease as measured by serum alkaline phosphatase levels
[19, 20]. Third, there is a steady increase in the age at
presentation by about 4 years per decade [18] and last, the
proportion of patients with monostotic disease is increasing
[18]. This in turn means that we are likely to see a higher
incidence of monostotic vertebral involvement in the future.
The spine is the second most commonly affected site
(53%) [6], after the pelvis (70%) [21–23]. The disease is
polyostotic in 66% of cases and between 35% [24, 25] and
50% [7, 8] have spinal involvement. Using multimodal
advanced imaging, this review article focuses on the
pathological processes that underlie the varied spinal
manifestations and complications of PD.
Pathomechanisms
In PD the loss of homeostatic control leads to increased
osteoblastic and osteoclastic activity and constitutes the
background for the main three phases. The initial lytic
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osteoblastic phase is characterised by new bone formation,
while the intervening mixed phase is seen when there is a
combination of osteoblastic and osteoclastic activities [24,
26]. One more phase, “inactive sclerotic phase”, charac-
terised by normal or decreased bone activity, has also been
described [5], when the stimulation of new osteoblast and
osteoclast formation ceases. Although the bone is metabol-
ically inactive, it maintains a sclerotic coarsened architec-
ture [27]. In bones with a low trabecular/cortex ratio like
the skull, femur and humerus, the early lytic phase is
radiologically depicted by a clear leading edge at the
interface with normal bone. The lytic phase is usually not
detected in bones with a high trabecular/cortex ratio like the
vertebra, sacrum and pelvis [28]. Vertebral body involve-
ment at radiological diagnosis is virtually always complete,
and therefore the leading edge present in the other affected
bones is not seen in the vertebra [29]. These phases can be
evident in the same patient and at the same time in different
bones including the vertebral column. Although progres-
sion of disease occurs within an affected bone, the sudden
appearance of bone involvement at new skeletal sites years
after the initial diagnosis is uncommon [30, 31].
The pathomechanisms and the dynamics involved in
bone remodelling in PD of the appendicular and axial
skeleton at the periosteal and endosteal surfaces have
been previously described [3, 5, 32]. The enhanced
abnormal osteoblastic activity results in periosteal and
endosteal new bone formation (apposition). The abnormal
osteoclastic activity on the endosteal surface results in
bone resorption (absorption). The various combinations of
these mechanisms give rise to four different patterns of
bone remodelling at the periosteum/endosteal interface
leading to bone enlargement: periosteal and endosteal
apposition; periosteal apposition and endosteal absorption;
periosteal apposition with normal endosteal surface; and
focal periosteal apposition –“pumice stone” appearance
(Figs. 1, 2). The mechanisms in the spine commonly
responsible for the changes on the periosteal and endosteal
surfaces of the vertebral body and posterior neural arches
are varied (Figs. 1, 2, 3, 4). These various mechanisms are
not exclusive of each other, but can occur in combination
in the same vertebra at various borders. Usually, one of the
pathomechanisms predominates in the involved vertebra.
The most frequent mechanism of vertebral body expansion
is periosteal apposition and endosteal absorption. The new
bone formation predominates on the periosteal surface and
it is responsible for the vertebral body enlargement, while
the absorption on the endosteum results in an increased
bone marrow space. Periosteal/endosteal apposition and
periosteal apposition with normal endosteal surface are two
less common remodelling mechanisms seen in the verte-
bral body. In both, the apposition on the periosteal side
results in vertebral body enlargement, but the bone marrow
space is decreased or normal in size respectively. The least
common mechanism of vertebral body expansion is focal
periosteal apposition giving the “pumice stone” appearance
(Figs. 1, 2). Expansion of the vertebral bodies seen
radiologically occurs in 63% of cases [25]. The commonest
mechanisms in neural arch involvement are a combination
involving periosteal and endosteal apposition or periosteal
apposition and endosteal absorption (Figs. 3, 4). In both of
the mechanisms, the periosteal apposition causes a de-
crease in the size of the spinal canal resulting in spinal
stenosis.
Imaging manifestations
Paget’s disease of the spine can either involve a single level
or more than one level. The lumbar spine and more
commonly the L4 and L5 levels are the most frequently
involved sites (58%) [33], more so than the thoracic (45%)
and the cervical vertebrae (14%; Fig. 5)[ 8, 23]. Involve-
ment of the atlanto-axial region is very rare [8, 34, 35]. The
vertebral body is almost always involved together with a
variable portion of the neural arch. Isolated involvement of
either the neural arch or the vertebral body is evident in
only a small percentage of cases [25].
Osseous changes (vertebral body)
The radiological appearance of vertebral body expansion is
characterised on radiographs by an increase in the antero-
posterior and lateral vertebral dimensions. However, the
height of the vertebra is unchanged. The bony vertebral
end-plates are subchondral condensations of trabecular
bone and do not represent true bony cortex, i.e. there is
no periosteum/endosteum interface at the caudal/cranial
aspect of a normal vertebra. The sagittal and lateral
enlargement is due to one of the previously described
pathomechanisms in the corticated portions of the vertebral
body. The pathomechanisms are best appreciated on CT
(Fig. 2), where the periosteal contour and the endosteal
interface due to apposition and absorption are easily seen.
Whatever the mechanism causing vertebral body remodel-
ling, bone expansion is a common denominator in PD.
Usually, the earliest phase seen radiologically in the
vertebra is the mixed phase. The apparently “early”
radiographic appearance of vertebral body involvement in
PD is thickening and hypertrophy of the trabecular bone
[36, 37], parallel to the end plates (Fig. 6), which can
appear similar to a thickened cortex. CT reconstruction
images can show this thickening and hypertrophy optimally.
The combination of trabecular bone hypertrophy and
thickening at the end-plates with apposition/absorption on
610 Skeletal Radiol (2007) 36:609–626the periosteal/endosteal surfaces at the anterior and posterior
vertebral borders leads to the “picture frame” sign [36].
Radiographs demonstrate increased density in the vertebral
periphery and a relatively lucent centre in the vertebral
body [36, 38, 39], best appreciated on lateral views and on
sagittal CT reconstructions (Fig. 6).
Progression of the sclerotic phase in the spine leads to
“ivory vertebra”, due to an increase in the density of the
Fig. 1 Diagram depicting the
osseous mechanisms involved
in vertebral body enlargement in
Paget’s disease and its effect on
the size of the marrow (dashed
arrows) and cortex (solid
arrows). A normal vertebra is
depicted in the centre of the
figure. a Periosteal apposition,
normal endosteum resulting in
thickened cortex, but with nor-
mal marrow size. b Periosteal
apposition, endosteal resorption
results in normal cortical thick-
ness and an increased marrow
size. c Periosteal apposition/
endosteal apposition results in a
thickened cortex and reduced
marrow size. d Focal periosteal
apposition results in a focal
“pumice stone”-like
enlargement
Fig. 2 Axial CT sections in
different patients showing the
various mechanisms described
in Fig. 1 and their effect on
marrow size (long white arrow)
and cortical thickness (short
white arrow). a Periosteal ap-
position, normal endosteum.
b Periosteal apposition, endos-
teal resorption. c Periosteal and
endosteal apposition. d Pumice
stone type (dashed arrow)o f
focal periosteal apposition.
Similar focal periosteal apposi-
tion of the spinous process is
seen
Skeletal Radiol (2007) 36:609–626 611vertebral body, denser than the normal vertebral bodies.
There is no change in the density and size of the adjacent
intervertebral disc [40, 41]. Differential diagnoses of “ivory
vertebra” include metastases, osteosarcoma, carcinoid and
Hodgkin’s lymphoma [29, 36]. The increased size of the
vertebral body is a useful clue to the underlying diagnosis
of PD. Biopsy may be necessary in some cases when there
is no expansion (Fig. 5).
In the exceptionally rare cases of vertebrae presenting in
the lytic phase, there is marked osteopenia of the vertebra
on radiographs, giving a “ghost vertebra” appearance,
because of the almost complete involvement of the
vertebral body by the osteolytic process [42]. The lytic
phase of PD involving the axis [43] and a rare pathological
collapse of a purely lytic L5 vertebra [44] have been
previously reported. It can be difficult to differentiate the
lytic phase of PD from other causes of osteolysis and
collapse. By demonstrating the cortical thickening, trabec-
ular hypertrophy and vertebral expansion, CT confirms the
lytic phase in the vertebral components due to the higher
contrast resolution, the feasibility of “bone window”
settings and multiplanar reconstructions.
The trabecular hypertrophy and cortical thickening
caused by the osseous involvement by PD results in a
variable degree of low signal on both T1- and T2-weighted
images. In the severe cases of vertebral sclerosis (ivory
vertebra appearance) the whole vertebra demonstrates a
diffuse low signal on both T1- and T2-weighted sequences.
More commonly however, the signal characteristics are
heterogeneous on both T1- and T2-weighted sequences due
Fig. 3 Diagram showing the
periosteal and endosteal Pagetic
osseous mechanisms involving
the cortex of the spinal canal
resulting in spinal canal nar-
rowing. Normal cortical thick-
ness (orange) of the spinal canal
(white) is depicted at the top.
a Expansion of bone due to
periosteal apposition/endosteal
resorption results in a thin cor-
tical outline (solid black arrow)
of the narrowed spinal canal
(dashed arrow). b Bony expan-
sion due to periosteal apposi-
tion/endosteal apposition results
in a thickened cortical outline
(solid black arrow) of the
narrowed spinal canal (dashed
arrow)
Fig. 4 Axial CT images dem-
onstrating the mechanisms in the
posterior neural arch described
in Fig. 3 and their effect on
cortical thickness (solid arrow)
and marrow size (dashed ar-
row). a Periosteal apposition/
endosteal resorption. b Perioste-
al apposition/endosteal
apposition
612 Skeletal Radiol (2007) 36:609–626to changes in the intervening marrow space. PD of the
vertebra is easily missed or misinterpreted on MR images in
the early stages. This is especially true when there is an
absence of classic changes including vertebral enlargement
and cortical thickening. This is mainly because PD is a
disorder of bone and the vertebral marrow is only
secondarily affected. MRI can show discrete areas of
marrow signal alteration involving vertebral bodies with
Fig. 6 a Lateral and b antero-posterior radiographs demonstrate
expansion of the vertebra with characteristic sclerotic lines parallel to
the end-plates due to trabecular hypertrophy, an Bearly^ sign of PD.
c Lateral radiograph in a different patient demonstrates the Bpicture
frame^ vertebra due to thickening of the cortex and trabecular
hypertrophy at the end-plates
Fig. 5 Vertebral Paget’s disease
(PD) without expansion in two
different patients. a PD of all the
cervical vertebrae except C6.
Note the absence of vertebral
enlargement. There is sclerosis
and loss of cortico-medullary
differentiation of the vertebral
bodies and the neural arches.
b antero-posterior, c lateral
radiographs and d axial CT
through the L1 vertebra demon-
strating sclerotic vertebra with
no enlargement. The axial CT
demonstrates trabecular and
endosteal apposition, but no
periosteal apposition accounting
for the absence of enlargement.
Diagnosis can be difficult and a
biopsy (c) may be necessary in
these cases
Skeletal Radiol (2007) 36:609–626 613low non-specific signal on T1-weighted images and high
signal on T2-weighted sequences. The marrow changes due
to vertebral involvement by PD are described in detail later.
Osseous changes (posterior elements)
Neural arch involvement can be difficult to evaluate on
radiographs alone. The best modality for neural arch
assessment is CT with reconstructions.
When periosteal and endosteal apposition occur, a
markedly sclerotic cortex can be seen [5, 8]. However,
when the basic mechanisms are periosteal apposition and
endosteal absorption, CT demonstrates an enlarged marrow
space of the neural arch delineated by a thin sclerotic line
due to the periosteal apposition (Fig. 4). Both processes
result in a decrease in the spinal canal diameter.
The presumed epidural fat ossification as previously
described in Paget’s disease [45], results in the loss of the
normal MR signal of epidural fat. This is probably a
consequence of expanded Pagetic bone growth out of the
neural arch components towards the spinal canal, reducing
its size, rather than real ossification of the epidural fat. This
can be misinterpreted as epidural fat ossification on radio-
graphs and MR imaging and is best assessed on axial CT
images (Fig. 7). Sometimes, however, the fatty marrow
changes in the expanded Pagetic posterior neural arch can
be misinterpreted on MR imaging as epidural lipomatosis
(Fig. 8). CT again helps in the correct interpretation of this
situation. This emphasises the need for a combination of
imaging modalities to complement each other for accurate
interpretation.
Bone scintigraphy using 99-Technetium substrates and
SPECT can aid the diagnosis of PD, showing a typical
distribution of the disease. Scintigraphy demonstrates
increased uptake in all the affected vertebral components
[46, 47] because of its sensitivity to osteoblastic activity
and can be very useful in showing activity in the posterior
neural arch. As a whole body imaging modality, it also
provides information about the overall distribution of the
disease. Moreover, the fourth sclerotic inactive phase
described by Milgram is diagnosed essentially on a bone
scan where radiographically affected bone does not dem-
onstrate increased activity due to the metabolic inactivity of
the lesion [27]. However, increased activity on bone
scintigraphy is usually non-specific and requires compari-
son with radiographs/CT. Various patterns of uptake are
described on bone scintigraphy in PD [21, 46, 48, 49], all
of which are non-specific.
Imaging techniques such as PET and PET-CT, can
contribute to the differential diagnosis of PD from other
disorders in the spine, especially when non-specific PD
changes are incidentally discovered, and to assess disease
activity after treatment.
In general 18F-fluoride positron emission tomography
(PET) allows visualisation of the regional skeletal meta-
bolic activity on the basis of the fluoride uptake on the bone
surface when new bone formation and blood flow are
greater [50]. The advantages of PET-CT on conventional
nuclear bone scintigraphy include superior spatial resolu-
tion and more accurate quantification of bone activity. In
PD, a general increase in global skeletal blood flow,
measured by fluoride deposition, is seen associated with a
regional increased uptake in the affected bone. Increased
activity in the pagetic bone is usually recorded almost
immediately after the injection and it remains high
throughout the duration of the study. However, this finding
is not specific to pagetic bony changes, giving rise to some
false-positives. For this reason, the combination of non-
Fig. 7 a Sagittal T1-weighted
MR image demonstrates PD in
the L3 vertebral body and the
posterior neural arch. The low
T1 signal intensity mass (arrow)
replacing epidural fat can be
confused with epidural ossifica-
tion. b However, an axial CT
image confirms this to be due to
expansion of the pagetic neural
arch and not to ossification of
the epidural fat. There is preser-
vation of the intra-osseous fat as
seen on both the MR and CT
images, a useful discriminant
from malignant infiltration
614 Skeletal Radiol (2007) 36:609–626specific activity on the PET image, the findings on the CT
scan (PET-CT) and the correlation with other radiological
examinations increases specificity [51].
Extra-osseous changes
Paget’s disease can sometimes involve the soft tissue
attached to the affected vertebra including the articular
cartilage, the ligaments and the intervertebral disc [26, 45].
The articular facets are commonly involved in associa-
tion with vertebral body and neural arch involvement. The
affected facets are enlarged and sclerotic (Fig. 9). The
pagetic vertebral body involvement can interfere with
the nutrition of the intervertebral disc leading to its
degeneration due to sclerosis adjacent to the end-plates
resulting in decreased diffusion [26].
Occasionally pagetic involvement of the spine can also
produce extra-osseous extension resulting in ossification of
the anterior/posterior longitudinal ligaments and ligamenta
flava. Lateral radiographs and CT sagittal reconstruction
demonstrate the ossified anterior and posterior longitudinal
ligaments. The ligamenta flava ossification are seen on the
AP view as radio-opacities adjacent to the facet joints. Para-
vertebral soft tissue swelling seen radiographically or by
CT can be due to extra-medullary haematopoiesis. When
PD of spine results in extra-medullary haematopoiesis [52],
there is extra-osseous soft tissue with signal characteristics
similar to the adjacent vertebral marrow. CT and MRI
Fig. 8 Paget’s disease of T11 and T12 showing an increased amount
of high MR signal (solid white arrow) in the posterior epidural space
at these levels on a sagittal T2-weighted, b sagittal T1-weighted and
c axial T1-weighted images. This can be mistaken for epidural
lipomatosis. However, the d CT sagittal and e axial images
demonstrate this to be due to the fat density (solid white arrow)
within the expanded posterior neural arch involved in PD. The axial
images (c,e) were obtained at the level of the tip of the solid arrows on
sagittal images. There is also fusion of the vertebrae (dashed arrow)
across the intervertebral disc. The combination of anterior and
posterior vertebral involvement in this case resulted in severe spinal
canal narrowing and cord compression. Note the high T1 signal
indicating a high fatty marrow content within the pagetic T11 and T12
vertebrae
Skeletal Radiol (2007) 36:609–626 615demonstrate the soft tissue mass adjacent to the vertebral
body (see Pathological complications) in communication
with the bone marrow within the vertebra [52].
Bone marrow
Paget’s disease is primarily a disorder of bone and not of
the bone marrow. Secondary bone marrow changes do,
however, occur. The marrow signal changes in established
Paget’s disease have been well described and vary with the
stage of the disease [53]. Low signal on T1-weighted
images and mild high signal on T2-weighted images
(Fig. 8) in the mixed hypervascular phase are seen. The
sclerotic phase of PD results in low signal on both T1- and
T2-weighted images in the vertebra due to increased
trabecular thickness, sclerosis and marrow fibrosis
(Fig. 10). There is fatty transformation in the latter stages
when there is high signal on both T1- and T2-weighted
images (Fig. 11). In the presence of osteolysis in pagetic
vertebrae, a fat signal within the lesion is a useful clinical
determinant between conservative management and biopsy
in cases in which malignancy is suspected radiographically
[54].
Whenever vertebral bone marrow signal changes are
seen on MRI, PD has to be considered in the differential
diagnosis because of its non-specific and varied appearance
in the bone marrow, and subtle bony alterations suggestive
of PD have to be sought. Paget’s disease can, however, also
coexist with other disorders.
When the bone marrow is not or only minimally
involved (Fig. 12) in PD, MRI will not reveal an
appreciably altered signal on either T1- or T2-weighted
images. The seemingly normal MR appearance of the
vertebra does not exclude PD, but affirms only the normal
Fig. 10 a Initial scintigraphy for back pain demonstrates isolated
increased uptake at a single vertebral level (T8). On initial inspection
sagittal b T1-weighted and c T2-weighted MR images do not show
any abnormality of the vertebral body. There is, though, some
abnormal low signal from the posterior elements (black arrow). The
diagnosis is still not clear. d However, a CT scan demonstrates the
clear posterior vertebral (black arrow) sclerotic changes consistent
with PD. Even on CT there are only minimal changes in the vertebral
body
Fig. 9 Facet involvement.
a Axial CT section demonstrates
incongruity at the facet joint
(solid white arrow) due to an
involved enlarged facet of one
vertebra articulating with an
uninvolved non-expanded adja-
cent vertebral facet. b Axial CT
section in a different patient
demonstrates advanced facet
joint arthropathy (dashed white
arrows) across two pagetic fac-
ets with complete loss of joint
space and new bone formation
contributing to spinal canal ste-
nosis. This can progress to fu-
sion across the facet joints
616 Skeletal Radiol (2007) 36:609–626appearance of the bone marrow, while the intervening
trabecular bone is affected. For this reason, vigilance in
recognising subtle signs like minor antero-posterior verte-
bral expansion and minimal cortical thickening is necessary
as the signal characteristics within the centre of the vertebra
may be entirely normal. MRI should be complemented by
radiographs and CT in these instances (Figs. 10, 11, 12).
PD is fundamentally a bone disorder, where the bone
marrow may or may not be involved, showing areas of
sclerosis, fibrosis, increased vascularity, residual haemato-
poiesis and fatty marrow replacement, resulting in a wide
spectrum of MR signal features. For this reason, all these
described MR findings need the comparison of radiographs
and CT images, because only these imaging modalities are
actually capable of showing the specific and pathognomonic
bony changes of PD. The aim of the integration of different
Fig. 11 On initial examination, a sagittal and b parasagittal T1-
weighted, c sagittal and d parasagittal T2-weighted MR images of the
lumbar spine do not demonstrate any obvious abnormality. e, f The
radiographs, however, show classic pagetic changes of the L1 vertebra
(dashed arrows) including vertebral expansion, sclerosis and cortical
thickening. Review of the MRI shows some minor increased signal in
the expanded L1 vertebral body on both T1 and T2 parasagittal
images, suggestive of fatty marrow change (white arrows)
Skeletal Radiol (2007) 36:609–626 617techniques is to make a correct diagnosis and avoid
unnecessary biopsy.
Pathological complications
Pagetic bone is structurally weak. Despite this, the involved
vertebral body and posterior neural arch still have to fulfil
the biomechanical role they were designed for. The disease
will alter the normal metabolic function in the bone while
biomechanical forces in turn modify further the metabolic
and structural changes that arise. Various clinical compli-
cations can occur secondary to vertebral PD resulting in
back pain, spinal stenosis and neural dysfunction. Whilst
each of these clinical symptoms can be caused by a variety
of pagetic complications, it has to be stressed that PD and
its complications can be entirely asymptomatic[21]. More-
over, the symptoms could be due to other coexisting spinal
disorders.
Back pain is the most common clinical symptom
associated with PD of the spine (Table 1). However, not
all patients with PD of the spine are symptomatic [21].
Back pain in PD is due either to the disease itself or to the
occurrence of different complications (Table 1). Back pain
due to the PD itself is caused by an increased blood flow
and modelling/remodelling process associated with the
vertebral involvement including periosteal stretching and
micro-fractures. In general, pagetic pain is a deep, dull ache
or pain in the back that is unrelated to activity and not
relieved by rest or non-steroidal anti-inflammatory medica-
tion. This pain is different from mechanical pain, which
improves with rest and worsens with activity or a stressful
posture of the back. It is also different from arthritic pain,
characterized by aching and stiffness that is relieved by
walking or by anti-inflammatory medication [24]. Between
11 and 54% [5, 55] of pagetic patients present with pain. In
24% of cases, back pain is due to PD itself [5, 8, 24]. In
50% of cases, it is due mainly to other complicating factors
including fracture, spinal stenosis and facet arthropathy;
less commonly it is due to spondylolysis with or without
spondylolisthesis and discal involvement [26]. Another
study found 88% of cases with back pain related to
coexisting PD and osteoarthritis of the spine versus 12%
of patients with pain attributed only to PD [56]. No
particular difference in pain has been seen in multilevel
involvement compared with single level involvement [24].
Spinal stenosis in PD of the spine has a prevalence of
33% of cases (Table 2)[ 5]. It is graded as mild if it is just
perceptible, moderate if the area of the spinal canal is
reduced by less than 50% and severe if that area is reduced
by more than 50% [24, 25]. Spinal stenosis can present
clinically as back pain and/or neurological dysfunction, as a
consequence of cord (Figs. 8, 13) or nerve root compres-
sion. In some cases, spinal stenosis is not associated with
back pain. Patients with severe stenosis seen on imaging
can present without clinical symptoms and patients with
mild or moderate stenosis can present with back pain [24].
This is possibly explained by the adaptability of the thecal
sac and its neural elements to severe spinal stenosis without
significant loss of function [5, 24]. The proportion of
symptomatic patients with spinal stenosis ranges from 26%
Fig. 12 a T1-weighted, b T2-
weighted sagittal images of the
lumbar spine demonstrate no
marrow abnormality. There is
only a subtle antero-posterior
expansion of the L2 and L4. The
diagnosis in these patients can
be missed on initial MRI.
c Lateral radiograph of the lum-
bar spine demonstrates the clas-
sic pagetic changes including
vertebral expansion, trabecular
hypertrophy and cortical thick-
ening in L2 and L4. There is an
incidental non-pagetic vertebral
compression at L1. There is
again preservation of the fat
signal within the vertebrae in-
volved in PD
Table 1 Causes of back pain in Paget’s disease
Periosteal stretching
Vascular engorgement
Microfractures
Facet arthritis
Intervertebral disc disease
Overt fractures of vertebrae, sacrum
Spondylolysis/-listhesis
Sarcoma—very rare
618 Skeletal Radiol (2007) 36:609–626[57] to 33% [5]. Seventy-five per cent of these cases
present with pain, but without neurological dysfunction
[25]. Expanded pagetic bone involving all vertebral
components (vertebral body, neural arch and facet joints)
is the commonest cause of spinal stenosis (Fig. 13). It was
reported by Wyllie in 1923 [58]. It is a consequence of a
disturbance in the bone remodelling process, leading to a
subsequent decrease in the spinal canal size [5, 24]. Less
frequently, the stenosis can be due solely to expansion of
the neural arch associated with the growth of pagetic bone
involving the facets [8].
Spinal stenosis in Paget’sd i s e a s eh a st h eu n i q u e
radiographic feature of widening of the interpediculate
distance on the antero-posterior view, with expansion of the
vertebral body on the lateral view. CT is very useful for
assessing the contribution of the facets and neural arch to
the stenosis, not seen well on radiographs (Fig. 14). CTalso
helps to assess the location of the expanded bone to
determine if the stenosis is central or lateral and to assess
the severity of the stenosis. In cases in which cord
compression due to the spinal stenosis is suspected, the
diagnostic tier has to be completed by performing an MRI
scan (Figs. 8, 13)[ 8, 24, 59]. Axial and sagittal images
demonstrate the bone abnormalities, but they can also show
myelomalacia in the spinal cord. The sagittal T2-weighted
images show the pagetic bone compressing the cord with
no evidence of normal CSF surrounding the cord. The axial
images show the asymmetry or deformation in shape of the
cord compressed by the expanded bone. Areas of myelo-
malacia demonstrate low cord signal on T1-weighted
images and high signal on T2-weighted and STIR images,
at the same level as the expanded pagetic bone.
Neural dysfunction can be due to spinal stenosis (33%)
[24, 60], more frequently with thoracic spine involvement
and less commonly with cervical spine involvement [61].
The less frequent neural involvement in lumbar spine
involvement is due to the relatively capacious spinal canal
in the lumbar region [5, 57, 62]. Although the pagetic
process itself, together with compressive effects from the
expanding bone, can give rise to symptoms and signs, other
complications may develop and contribute to the symptoms
complex of neural dysfunction (Table 2). Patients present-
ing with neurogenic pain due to cord compression by
expanded pagetic bone (Fig. 20) can also respond well to
medical treatment with calcitonin and bisphosphonates
[63]. Surgical decompression is rarely necessary in cord
compression as stenosis and neural dysfunction in PD may
respond to medical treatment alone [5]. The “arterial steal
phenomenon” is another factor contributing to neural
dysfunction. This is described as a deprivation of blood
supply to the spinal cord due to the preferential blood flow
of the pagetic vertebra (Fig. 15)[ 64]. It is classified as a
non-compressive spinal cord dysfunction and not directly
related to pagetic bone growth and it can respond very well
to treatment with calcitonin [64–66].
Compression fracture
Compression fracture of the vertebral body is the common-
est complication in PD of the spine and usually presents
with sudden onset of back pain (Fig. 16). It occurs more
Table 2 Causes of neural dysfunction in Paget’s disease
Posterior expansion of the vertebral body
Posterior neural arch expansion
Facet joint arthritis/overgrowth
Ligament ossification
Spondylolisthesis
Fracture retropulsion
Extra-osseous involvement—PD, haematopoiesis, “pseudosarcoma”,
malignancy
“Arterial steal” syndrome
Fig. 13 Sagittal T2-weighted MR image demonstrates cauda equina
compression at the L1 level due to pagetic enlargement of the whole
vertebra. Note the stenosis caused by expansion of both the vertebral
body and posterior elements. Degenerative spondylolisthesis and
stenosis at L4/L5 is noted
Skeletal Radiol (2007) 36:609–626 619frequently in the lumbar spine [59], and rarely in the
sacrum [59], the coccyx [67] and the odontoid peg.
Para-vertebral swelling can be seen as an indirect sign of
the vertebral fracture in the acute phase. The fracture line
itself is best seen on CT with sagittal reconstructions.
Vertebral fracture can also contribute to the pain related to
spinal stenosis by two mechanisms: posterior vertebral
body wall bulging and retropulsion (Fig. 16) of a bone
fragment into the spinal canal [8, 68], and cord compres-
sion. This can be recognised on radiographs in the lateral
view and is associated with a decrease in the spinal canal
size, but CT demonstrates this better.
The fractured vertebra in PD sometimes appears osteo-
penic on radiographs. This could be due to a fracture
occurring in the lytic phase of PD. However, as described
earlier, it is unusual to see the lytic phase of PD in the
spine. The osteopenia is most likely due to fracture-induced
osteolysis. MRI can also contribute to the diagnosis of a
compression fracture, even if its findings are not specific.
The fracture line is seen as a linear or curvilinear low signal
on T1-weighted images and high signal on T2-weighted
and STIR images. Oedema surrounding the fracture can be
an indirect sign. It is seen as high signal on inversion
recovery and T2-weighted images and low signal on T1-
weighted images. When the fracture is not recent, the signal
on the MRI scan will be low on both T1- and T2-weighted
images because of the sclerosis of the bone. In general,
diffusion weighted imaging can help to differentiate
osteoporotic from malignant vertebral body collapse [69].
It is not yet known if benign fracture in PD can be mistaken
for a malignant compression on diffusion weighted imaging
given the associated underlying marrow changes prior to
the occurrence of the fracture.
Facet joint arthropathy
Facet joint involvement can cause back pain, lateral spinal
stenosis and neural dysfunction. Facet involvement can lead
to facet joint arthropathy due to two mechanisms. One is
the direct extension of PD into the articular cartilage similar
to that seen in large synovial joints and the intervertebral
Fig. 14 Post-myelographic lat-
eral lumbar spine a radiograph
and b axial CT scan demonstrate
spinal block at the L1 vertebral
level, which is pagetic. Note the
severe degree of spinal stenosis
despite the apparent increase in
the interpedicular distance on
the axial CT image
Fig. 15 Sagittal fat suppressed T1-weighted image after gadolinium-
DTPA administration in the same patient as in Fig. 8 demonstrates
intense enhancement at both the T12/L1 and the L3/L4 levels
(arrows). The enhancement in part reflects increased blood supply to
the vertebra
620 Skeletal Radiol (2007) 36:609–626disc [26], the other is the pagetic involvement of the facets
leading to expansion of the facet and resultant incongruity
with the apposing uninvolved facet (Fig. 9). Facet joint
arthropathy was noted in 17 out of 21 symptomatic patients
with back pain in one study [25]. This gives rise to
mechanical stress and early degenerative changes in the
facet joint. This is one of the most important factors in back
pain and also contributes to spinal stenosis. The spinal
canal stenosis associated with facet joint arthropathy is
typically lateral and can result in nerve root compression
[5]. Patients with severe arthropathy often have symptoms
of spinal stenosis, but they can be asymptomatic [24, 25].
Compared with radiography, CT gives a clearer depiction of
facet joint changes (Fig. 9), showing the loss of articular
space, the destruction of cartilage associated with subchon-
dral erosion and articular incongruity (Fig. 9)[ 5, 26, 70].
Facet joint arthropathy may eventually lead to ankylosis of
the articular space [25]. MR imaging can underestimate the
bony changes associated with the facet involvement.
Spondylolysis and spondylolisthesis
Back pain may be also due to unilateral or bilateral
spondylolysis if the pars interarticularis is involved in PD.
PD, due to the associated modelling/remodelling activity,
results in an increased susceptibility to insufficiency
fractures. A lateral radiograph may demonstrate the typical
spondylolysis (Fig. 17). However, due to the associated PD
and sclerosis, this can be difficult to appreciate. CT is the
best modality to detect this. Underestimation of this
Fig. 16 Lateral and anteropos-
terior radiograph of the lumbar
spine demonstrates severe com-
pression of a pagetic L3 vertebra
with retropulsion into the spinal
canal. Note the increased inter-
pediculate distance as a
hallmark of PD
Fig. 17 Lateral radiographs in
two different patients with PD
showing two different mecha-
nisms of spondylolisthesis:
a spondylolytic (arrow)
spondylolisthesis; b degenera-
tive spondylolisthesis
Skeletal Radiol (2007) 36:609–626 621complication on radiographs and the relatively limited use
of cross-sectional imaging in PD may be the reason for the
under-reporting of this condition.
Spondylolisthesis in PD can be due to either spondylol-
ysis or facet joint degeneration (Fig. 17). It is important to
differentiate between the two entities. The degenerative
spondylolisthesis results in spinal stenosis and neural
dysfunction. The lateral radiograph is quite useful for
detecting spondylolisthesis and to establish its grade and
severity. However, this can be underestimated if the vertebral
alignment is not assessed carefully. An enlarged vertebra due
to PD may slip anteriorly over a normal vertebra, but the
posterior vertebral body alignment may still be preserved due
to the posterior expansion. The assessment of the posterior
neural arch alignment, however, will reveal the subtle slip in
these cases. The standard lateral radiograph can be com-
plemented by dynamic views in flexion and extension, which
can reveal the presence of spondylolisthesis under stress.
Fig. 18 Disc involvement. Seri-
al radiographs 2 years apart in
the same patient demonstrate
progressive involvement of the
L4/L5 intervertebral disc in
Paget’s disease of the L5
Fig. 19 Extra-osseous Paget’s
disease. a Sagittal CT recon-
struction and b T1-weighted
MR sagittal image demonstrate
anterior longitudinal ligament
ossification (white arrows).
c, d Axial CT sections demon-
strate ossification in the
ligamentum flavum due to extra-
osseous PD (black arrows)i na
different patient. e Antero-pos-
terior radiograph in another pa-
tient demonstrates paravertebral
soft tissue swelling (dashed
arrows) producing the
“pseudo-sarcoma” appearance
622 Skeletal Radiol (2007) 36:609–626Spondylolisthesis, and particularly spondylolysis, can be
confirmed on CT with sagittal reconstruction images.
Intervertebral disc involvement
Paget’s disease can involve the intervertebral disc and cause
intervertebral disc degeneration. The incidence of direct
intradiscal transgression is about 10.7% [26]. In this study,
67% of patients with disc involvement presented with pain.
Twenty-two percent were asymptomatic. Therefore, disc
involvement can remain asymptomatic. Some studies
describe the presence of para-vertebral soft tissue involve-
ment without specific comment on the discal invasion by
PD [45, 68]. PD transgressing the intervertebral disc occurs
more often in the lumbar spine than in the thoracic and
cervical spine. The mechanism is not very clear. Interverte-
bral disc degeneration can be caused mainly by the
mechanical stress induced by asymmetry at the end plate
attachment of annulus fibrosis between a pagetic and a
normal vertebra, and also by direct invasion of the disc
space by the pagetic process. Aggressive pagetic invasion
at the disco-vertebral junction leads to pagetic tissue
replacement of the cartilage end-plate and subsequently of
the intervertebral disc. The direct resorption of the disc
tissue with subsequent pagetic bone replacement in the disc
is the most likely explanation [26]. PD can then invade the
adjoining vertebra across the disc space. This can also
occur by direct extension of PD along large pre-existing
degenerative bridging osteophytes [26]. Radiological inves-
tigations in disc involvement show progressive disc space
narrowing, loss of definition of the adjacent end-plates,
sometimes indistinguishable from spondylodiscitis, and
large degenerative osteophytes involved in PD (Figs. 8,
18). Intervertebral disc involvement can eventually lead to
pagetic vertebral ankylosis (PVA) with an incidence of
4.4% [26]. Ankylosis is commoner in men, affects the
thoracic spine in over 50% of cases [71] and is usually
asymptomatic. The fusion between the vertebral bodies is
easily appreciated as being due to Pagetic changes. The
mechanisms that promote intervertebral disc involvement in
PD are also in play when extra-osseous involvement of the
spinal ligaments and para-vertebral tissues is seen (Fig. 19).
Fig. 20 Vertebral metastasis
from colon carcinoma. Sagittal
a T1- and b T2-weighted MR
images demonstrate metastasis
in L2 and L4 vertebral bodies
seen as discrete lesions (white
arrows) with low signal on T1-
and high signal on T2-weighted
images. A further epidural lesion
(black arrow) is seen in the
spinal canal posteriorly at L3.
Note the pagetic changes with
expansion of L2 and L3
vertebral bodies
Table 3 Causes of paravertebral swelling in Paget’s disease
Extra-osseous extension
Fracture haematoma
Extra-medullary haematopoiesis
Paget’s sarcoma/other tumours
Paget’s pseudosarcoma
Skeletal Radiol (2007) 36:609–626 623Neoplastic transformation
Neoplastic transformation in pagetic bone is very rare in the
spine (0.7%) [5, 8, 24, 72] and represents only 7% [73]o f
all sarcomatous degeneration in PD. It can present with
back pain. Benign and malignant bone neoplasms can
complicate Paget’s disease. The majority of malignant
transformations are osteosarcomas. They seem to be related
to one or two genes on the chromosome 18q [5, 74, 75].
Radiologically, this is seen on radiographs and CT
images as a lytic lesion characterised by an aggressive
pattern on a background of typical PD. It can be very
difficult to diagnose this lesion on the radiographs because
of the overlapping pagetic changes in the bone. However,
as described earlier, it is unusual to see the lytic phase of
PD in the absence of other complicating factors like a
fracture. A para-vertebral soft tissue mass should always be
regarded as possible neoplastic transformation associated
with vertebral Paget’s disease, but more frequently is due to
benign causes (Table 3). On MR axial and sagittal images
the sarcomatous degeneration appears as a mass with
irregular edges showing low signal on T1- and inhomoge-
neous high signal on T2-weighted images [8]. The
preservation of the medullary fat signal on T1-weighted
images excludes malignant degeneration and can be an
extremely useful sign [54]. It usually shows inhomoge-
neous contrast enhancement after gadolinium administra-
tion because of its solid structure with internal vascularity.
The other differential diagnosis to be considered is extra-
medullary haematopoiesis. Less common is the “pseudo-
sarcoma”appearancecharacterisedbyextra-corticalperiosteal
bone expansion or by a bulky juxta-cortical soft tissue mass
similar in its characteristics on imaging to sarcomatous
degeneration(Fig. 19)[ 11, 76, 77]. Malignant transformation
can contribute to spinal stenosis [5]. For this reason the
radiological assessment is not only focussed on the presence
of a malignant mass, but also on the presence of cord
compression, well documented on sagittal T1- and T2-
weighted MR images. The spine is a common site for
metastatic disease and the secondary deposits may also
involve bones previously involved in Paget’s disease
(Fig. 20). A biopsy may be necessary to differentiate among
these various entities.
Conclusion
Recognition of the imaging manifestations of spinal PD and
the potential clinical complications enables accurate assess-
ment of patients prior to appropriate management. This
knowledge should allow subtle PD to be identified on
imaging when this is not suspected. This is especially
relevant to MRI, as it has become the imaging modality of
choice for investigating the spine. Patients presenting with
back pain and spinal stenosis have to be assessed for
pagetic complications before attributing the symptomatolo-
gy to the disease itself.
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